Raymond James Starts Covidien (COV) at Outperform
More News related to COV
- Covidien Recognized as Top Medical Devices Innovator
- Covidien Launches BariatricsPro.Com
- Covidien plc to Report Third-Quarter Results on July 30, 2009
- Covidien Features New Devices for Minimally Invasive Surgery and Soft Tissue Repair at ASMBS 2009
- Piper Jaffray initiates coverage on Covidien, Ltd. (COV) with a Neutral
Raymond James initiates coverage on Covidien (NYSE: COV) with an Outperform rating.
Covidien, Ltd. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings worldwide.
Related Categories
New CoverageStocks Mentioned
-6.91Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
